Menu
Live News EQUITY L impact

Allogene Therapeutics Files SEC Form

Allogene Therapeutics submits regulatory filing with the SEC. The filing is available for public review.

ALLO

Filed: 2026-05-28 AccNo: 0001193125-26-245501 Size: 25 KB